Fennec Pharmaceuticals Inc. (FENC)
NCM – Real vaqt narxi. Valyuta: USD
7.03
-0.07 (-0.99%)
Yopilishda: May 12, 2026, 4:00 PM EDT
7.03
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 4:10 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
7.03
-0.07 (-0.99%)
Yopilishda: May 12, 2026, 4:00 PM EDT
7.03
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 4:10 PM EDT
Fennec Pharmaceuticals Inc. Qo'shma Shtatlarda tijoriy bosqichdagi biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniyaning mahsulot nomzodi orasida PEDMARK mavjud bo'lib, u bolalarda cisplatin bilan bog'liq ototoksiklikning oldini olish uchun natriy tiosulfat formulasidir. Kompaniya o'z mahsulotlarini mintaqaviy pediatrik onkologiya mutaxassislari va tibbiy fan aloqadorlari orqali sotadi. Fennec Pharmaceuticals Inc. Tampa General Hospital Foundation, Inc. bilan hamkorlikda cisplatin asosidagi davolashni olgan o'smirlar, yoshlar va kattalar saraton bemorlarida ototoksiklik xavfini kamaytirishda natriy tiosulfat in'ektsiyasining klinik foydasini baholash uchun; va Norgine Pharma UK Limited bilan hamkorlik qiladi. Kompaniya ilgari Adherex Technologies Inc. nomi bilan tanilgan va 2014 yil sentyabr oyida Fennec Pharmaceuticals Inc. nomini olgan. Fennec Pharmaceuticals Inc. 1996 yilda tashkil etilgan va Shimoliy Karolina shtatidagi Tadqiqotlar uchburchagi parkida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Pierre S. Sayad M.S., Ph.D. | Chief Medical Officer |
| Mr. Jeffrey S. Hackman | CEO & Director |
| Mr. Lei Fang | President of Pharstat Inc |
| Mr. Mark Gowland | Controller |
| Mr. Robert C. Andrade | Chief Financial Officer |
| Mr. Terry Evans | Chief Commercial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-28 | DEF 14A | fencf-20260610xdef14a.htm |
| 2026-04-28 | 8-K | fencf-20260427x8k.htm |
| 2026-04-22 | 8-K | fencf-20260422x8k.htm |
| 2026-04-07 | 8-K | fencf-20260407x8k.htm |
| 2026-03-27 | 10-K | fencf-20251231x10k.htm |
| 2026-03-24 | 8-K | fencf-20260324x8k.htm |
| 2026-03-16 | 8-K | fencf-20260316x8k.htm |
| 2026-03-05 | S-8 | tm267832d1_s8.htm |
| 2026-03-04 | 8-K | fencf-20260304x8k.htm |
| 2026-02-20 | 8-K | fencf-20260220x8k.htm |
| Ms. Christiana Cioffi M.B.A. |
| Chief Strategy Officer |